Literature DB >> 29272379

Annual adverse event profiles after clopidogrel, prasugrel, and ticagrelor in the Food and Drug Administration Adverse Event Reporting System.

Vasily Cherepanov1, Seth D Fortmann1, Moo Hyun Kim2, Thomas A Marciniak3, Oleg Litvinov1, Kyryl Mihalev4, Victor L Serebruany1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29272379     DOI： 10.1093/ehjcvp/pvx038

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  2 in total

Review 1.  Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.

Authors:  Pravesh Kumar Bundhun; Feng Huang
Journal:  BMC Cardiovasc Disord       Date:  2018-05-02       Impact factor: 2.298

2.  Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases.

Authors:  Hiromi Hagiwara; Hidekatsu Fukuta; Takahiro Niimura; Yoshito Zamami; Keisuke Ishizawa; Kazunori Kimura; Takeshi Kamiya; Nobuyuki Ohte
Journal:  Int J Med Sci       Date:  2020-03-05       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.